IP Library › Granted Patent US 8,828,709
Granted Patent B2
US 8,828,709 · App. 11/920,123 · Granted Sep 9, 2014

Quantitative determination of proteins from formalin-fixed tissue

Inventors: Peter Porschewski (Langenfeld, DE); Karl-Friedrich Becker (Germering, DE)
Assignee: Qiagen GmbH
G01N33/6803C07K1/145G01N1/31C07K1/36G01N33/5082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,828,709
App. No.
11/920,123
Granted
Sep 9, 2014
Kind
B2
Abstract

The invention relates to a method with which proteins from formalin-fixed biological samples can be dissolved and subsequently quantified. The method makes it possible to extract intact full-length proteins from the samples and to conduct a subsequent analysis thereof.

Claims (20)

1. A method for the extraction of proteins from a formalin-fixed biological sample, comprising incubating the formalin-fixed biological sample in a buffer at a temperature that is sufficient to release the proteins, wherein the buffer comprises a detergent and no proteolytically active compound, and the biological sample in the buffer is first boiled and then incubated further at a temperature greater than 80° C. but is not further boiled.

2. The method according to claim 1 , wherein the biological sample is boiled in the buffer for 5 to 40 minutes.

3. The method according to claim 1 , wherein the biological sample is incubated at a temperature above 80° C. for a period of 20 minutes to 16 hours.

4. The method according to claim 1 , wherein the released proteins are intact.

5. The method according to claim 1 , wherein the detergent is sodium dodecyl sulphate (SDS), sodium deoxycholate, 3-((3-Cholamidopropyl)dimethylaminonio)-1-Propanesulfonic Acid (CHAPS), a non-ionic surfactant having a hydrophilic polyethylene oxide group and a hydrocarbon lipophilic or hydrophobic group (Triton X100), a non-ionic, non-denaturing detergent having an alkenylphenoxypolyethoxide group and an alcohol group (Nonidet P40) or polysorbate-20 (Tween20).

6. The method according to claim 1 , wherein the buffer additionally comprises at least one reducing agent selected from the group consisting of 1,4-dithio-DL-threitol, dithioerythritol (DTE), tris (2-carboxyethyl)phosphine (TCEP) or monoethanolamine (MEA).

7. The method according to claim 1 , wherein the biological sample, when it is a formalin-fixed sample embedded in paraffin, is deparaffinated before the protein extraction.

8. The method according to claim 1 , wherein after extraction the proteins are further fractionated.

9. The method according to claim 1 , wherein the extracted proteins are subsequently quantified.

10. The method according to claim 1 , wherein the extracted proteins are treated with at least one proteolytic enzyme selected from the group consisting of trypsin, chymotrypsin, proteinase K, papain, pepsin, pronase, endoproteinase Lys-C, and endoproteinase glu-C or at least one glycosidase selected from the group consisting of endoglycosidase H, N-glycosidase F, neuroaminidase and phosphatases.

11. The method according to claim 1 , wherein the proteins are used for at least one biochemical assay.

12. The method according to claim 1 , wherein the biological sample is a tissue sample.

13. The method according to claim 1 , wherein the proteolytically active compound is a protease.

14. The method according to claim 1 , wherein the sample is incubated at a temperature above 80° C. for more than 50 seconds.

15. The method according to 8 , wherein the extracted proteins are fractionated with one or several method stages.

16. The method according to claim 9 , wherein the quantification of the proteins is carried out by the method of Lowry or the bicinchoninic acid (BCA) method.

17. The method according to claim 11 , wherein the biochemical assay is a protein array.

18. The method according to claim 11 , wherein the biochemical assay is used to identify one or more diagnostically or clinically relevant marker proteins present in the biological sample.

19. The method according to claim 17 , wherein the protein array is a sandwich immunoarray, an antigen capture array or a direct protein array.

20. The method according to claim 18 , wherein the marker proteins from at least two biological samples are compared with one another.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2008
From: PORSCHEWSKI, PETER; BECKER, KARL-FRIEDRICH
To: QIAGEN GMBH
Reel/Frame 021704/0025 →
Priority Claims (1)
DE 10 2005 023 011 · May 19, 2005 · national
Continuity (1)
Related Publication 20090124510A1 · May 14, 2009